Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000029905-18-000006

10% owner bought 527,472 shares at $22.75 ($11,999,988)

From the SEC's structured data for this filing

Trades in this filing

BAYER AKTIENGESELLSCHAFT · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-01-05 Purchase : show line 1 in the form +527,472 $22.75 $11,999,988 5,632,802 I
Open-market purchases · 527,472 sh · avg $22.75 · $11,999,988
Loading xslF345X03/edgar.xml…